"Magnum Heart Institute (MHI) has been set up with an aim to provide world-class cardiac care in North Maharashtra. Chopda Medicare Institute and Research Centre Pvt Ltd. Through the generosity, co-operation and vision of the Directors Dr. Manoj Chopda & Dr. (Mrs.) Rashmi Chopda the hospital has grown from a 10 bedded hospital to a humongous 100 bedded Multi Super Speciality hospital in North Maharashtra. It is well known through out the city and neighboring towns for its outstanding treatment in Cardiology."

During the past decade, Magnum Heart Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Magnum Heart Institute" are "Secondary Prevention" (1 trials), "Stroke" (1 trials) and "Thromboembolism" (1 trials). Many other conditions were trialed in "Magnum Heart Institute" in a lesser frequency.

Most popular intervention types in "Magnum Heart Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ASA 100 mg" (1 trials), "Dabigatran etexilate" (1 trials), "Warfarin" (1 trials), "dabigatran etexilate" (1 trials) and "optional ASA as comedication" (1 trials). Other intervention names were less common.

The vast majority of trials in "Magnum Heart Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Magnum Heart Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Magnum Heart Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Magnum Heart Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".